Clinical Trial Update: Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the use of indocyanine green to reduce anastomotic leakage in colorectal surgery for colorectal cancer and Crohn disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Crohn Disease

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Colo-rectal Cancer, Crohn Disease | Phase 3 | Status: UNKNOWN